Skip to main content
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in:

01-01-2018 | Clinical study

CVD prevalence low in patients receiving ADHD medication

Published in: Reactions Weekly | Issue 1/2018

Login to get access

Excerpt

The prevalence of cardiovascular disorder (CVD) is generally low in patients receiving attention-deficit hyperactivity disorder (ADHD) medication,1 but increases with age, according to findings of a US study published in Drugs - Real World Outcomes. …
Footnotes
1
amphetamines, atomoxetine, dexmethylphenidate or methylphenidate
 
Literature
Fairman KA, et al. Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling? Drugs - Real World Outcomes : 5 Jan 2018. Available from: URL: https://​doi.​org/​10.​1007/​s40801-017-0129-2
Metadata
Title
CVD prevalence low in patients receiving ADHD medication
Publication date
01-01-2018
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2018
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-41074-6

Other articles of this Issue 1/2018

Quinidine

  • Case report

Warfarin

  • Case report

Levodopa/carbidopa/pramipexole/rasagiline

  • Case report

Dexmedetomidine

  • Case report

Calcipotriol

  • Case report

Pyrimethamine/sulfadiazine

  • Case report